Cabaletta Bio (CABA) Prepaid Assets (2018 - 2025)
Cabaletta Bio (CABA) recorded quarterly Prepaid Assets of $5.3 million in Q4 2025, up 13.87% quarter-over-quarter from $4.6 million in Q3 2025, and up 94.32% on a YoY basis from $2.7 million in Q4 2024.
Cabaletta Bio (CABA) Prepaid Assets (2018 - 2025) Analysis & Trends
Cabaletta Bio's Prepaid Assets history runs 8 years deep, the most recent figure standing at $5.3 million for Q4 2025.
- In Q4 2025, Prepaid Assets rose 94.32% year-over-year to $5.3 million; the TTM figure through Dec 2025 stood at $5.3 million (up 94.32% YoY), while the FY2025 annual figure was $5.3 million, up 94.32% from the prior year.
- Prepaid Assets was $5.3 million for Q4 2025 at Cabaletta Bio, up from $4.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $5.3 million in Q4 2025 to a low of $1.2 million in Q2 2023.
- Historically, Prepaid Assets has averaged $2.8 million across 5 years, with a median of $2.4 million in 2021.
- The sharpest annual moves came in 2021 and 2024: Prepaid Assets tumbled 52.41% in 2021, then surged 143.65% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $2.3 million in 2021, then dropped by 1.38% to $2.3 million in 2022, then soared by 41.71% to $3.2 million in 2023, then decreased by 16.29% to $2.7 million in 2024, then surged by 94.32% to $5.3 million in 2025.
- The last three Prepaid Assets figures came in at $5.3 million (Q4 2025), $4.6 million (Q3 2025), and $3.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.27 Mn |
| Sep 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 3.64 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.89 Mn |
| Dec 31, 2022 | 2.29 Mn |
| Sep 30, 2022 | 2.28 Mn |
| Jun 30, 2022 | 1.94 Mn |
| Mar 31, 2022 | 2.23 Mn |
| Dec 31, 2021 | 2.32 Mn |
| Sep 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 2.21 Mn |
| Mar 31, 2021 | 3.73 Mn |